Abstract

Veins have emerged as the origin of all other endothelial cell subtypes needed to expand vascular networks during developmental and pathological neoangiogenesis. Here, we uncover the role of the angioneurin Fibronectin Leucine Rich Transmembrane protein (FLRT) 2 in central nervous system (CNS) vascular development in the mouse. Early postnatal FLRT2 deletion reveals specific defects in retinal veins, impacting endothelial cell proliferation, sprouting and polarity that result in reduced tip cells at the vascular front. FLRT2 interacts with VE-cadherin and together with the endocytic adaptor protein Numb contribute to the modulation of adherens junction morphology in both retina and cerebral cortex in vivo. Utilizing expansion microscopy, we visualize the altered dynamic distribution of VE-cadherin in tissue of FLRT2 endothelial mutants. Additionally, FLRT2 in cortical vessels regulates the crosstalk between adherens and tight junctions, influencing blood-brain barrier development. Our findings position FLRT2 as a vein-specific regulator of CNS vascular development.

Llao-Cid et al find FLRT2 (Fibronectin Leucine Rich Transmembrane protein) is present in the veins and capillaries of the central nervous system, where it regulates vascular development and the formation of the blood-brain barrier by influencing VE-cadherin turnover.

Details

Title
Vascular FLRT2 regulates venous-mediated angiogenic expansion and CNS barriergenesis
Author
Llaó-Cid, C. 1   VIAFID ORCID Logo  ; Peguera, B. 1 ; Kobialka, P. 1 ; Decker, L. 1   VIAFID ORCID Logo  ; Vogenstahl, J. 2 ; Alivodej, N. 2 ; Srivastava, S. 1 ; Jin, J. 1 ; Kirchmaier, B. C. 1 ; Milla, C. 1 ; Schlierbach, H. 3 ; Schänzer, A. 3 ; Acker, T. 3   VIAFID ORCID Logo  ; Segarra, M. 4   VIAFID ORCID Logo  ; Acker-Palmer, A. 5   VIAFID ORCID Logo 

 Goethe University Frankfurt, Buchmann Institute for Molecular Life Sciences (BMLS), Institute of Cell Biology and Neuroscience, Frankfurt am Main, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721) 
 Goethe University Frankfurt, Buchmann Institute for Molecular Life Sciences (BMLS), Institute of Cell Biology and Neuroscience, Frankfurt am Main, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); Max Planck Institute for Brain Research, Frankfurt am Main, Germany (GRID:grid.419505.c) (ISNI:0000 0004 0491 3878) 
 Justus Liebig University Giessen, Institute of Neuropathology, Giessen, Germany (GRID:grid.8664.c) (ISNI:0000 0001 2165 8627) 
 Goethe University Frankfurt, Buchmann Institute for Molecular Life Sciences (BMLS), Institute of Cell Biology and Neuroscience, Frankfurt am Main, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); Cardio-Pulmonary Institute (CPI), Frankfurt am Main, Germany (GRID:grid.511808.5) 
 Goethe University Frankfurt, Buchmann Institute for Molecular Life Sciences (BMLS), Institute of Cell Biology and Neuroscience, Frankfurt am Main, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); Max Planck Institute for Brain Research, Frankfurt am Main, Germany (GRID:grid.419505.c) (ISNI:0000 0004 0491 3878); Cardio-Pulmonary Institute (CPI), Frankfurt am Main, Germany (GRID:grid.511808.5) 
Pages
10372
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3133866636
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.